AADvac1

AADvac1 is an investigational vaccine targeting tau proteins, which are implicated in neurodegenerative diseases like Alzheimer's. By inducing an immune response against pathological tau, it aims to prevent or slow the progression of cognitive decline. This approach is significant for longevity and health optimization as it addresses a major cause of age-related cognitive impairment.